Developing new drugs is a complex and expensive process with a high failure rate. In fact, only about one out of 250 preclinical compounds make it to FDA approv 4 July 2023
French drugmaker Sanofi has placed a strong emphasis on the adoption of artificial intelligence capabilities to facilitate its internal operations. 13 June 2023
The life sciences industry has always been subjected to transparency requirements. To help avoid compliance violations that may lead to penalties, many life sci 10 May 2023
Roche has announced the launch of the Institute of Human Biology (IHB), focussing on advancing research in the field of human model systems such as organoids. 5 May 2023
US biotech success story Moderna has turned to one of the world’s leading tech companies as it seeks to stay at the forefront of advancing mRNA medicines. 21 April 2023
There have been huge changes in the way highly regulated markets operate in recent years – caused by new regulations.technologies and demands.Manufacturers and 6 April 2023
It seems every other day we hear of a new cyberattack in the news and it’s clear that these attacks are becoming an ever-growing, global concern. 27 March 2023
Belgian drugmaker UCB has teamed up with US firm Aitia in an early drug discovery collaboration focused on the discovery and validation of new drug targets and 15 March 2023
Israel-based computational disease modelling company CytoReason and French pharma major Sanofi have announced an expansion of their collaboration. 23 January 2023
UK-based artificial intelligence (AI) firm InstaDeep is to be acquired by immunotherapy specialist BioNTech for $440 million plus up to $243 million in mileston 10 January 2023
German pharma major Boehringer Ingelheim and US tech-based therapy firm Click Therapeutics have announced the launch of an expanded collaboration on a second pr 20 December 2022
Artificial intelligence (AI)-driven drug discovery company Insilico Medicine has announced a multi-year, multi-target strategic research collaboration with Fren 9 November 2022
The pace of innovation and digital transformation is increasing in the life science industry.particularly regarding regulatory compliance.As a result of the pan 6 November 2022
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.